Although inhibition of CHOP improved pathological manifestations of pulmonary fibrosis, reduced hydroxyproline content, and level of Collagen I, no significant reduction in Fibronectin was observed (Fig. 6E). The gene discussed is FN1; the disease is pulmonary fibrosis.